Patents for A61P 17 - Drugs for dermatological disorders (106,455)
03/2005
03/24/2005US20050065327 Immunoglobulin specific to interleukin-13 (IL-13) for use in prevention and treatment of asthma, fibrosis, skin and cell proliferative disorders
03/24/2005US20050065321 Cytokine receptor (Zcytor16) for use as tool in prevention and treatment of cell proliferative and nervous system disorders
03/24/2005US20050065251 For cosmetic/dermatologic use; for protecting skin and lips
03/24/2005US20050065212 Use of at least one 10-hydroxy-2-decenoic acid derivative in compositions for treating the cuteous signs of aging
03/24/2005US20050065195 Oxadiazolyl-biphenylcarboxamides and their use as p38 kinase inhibitors
03/24/2005US20050065170 Compounds
03/24/2005US20050065148 Dipeptidyl peptidase inhibitors
03/24/2005US20050065116 Thiazolopyrimidines useful as TNFalpha inhibitors
03/24/2005US20050065112 Antiproliferative agents; low toxicity; psoriasis; antitumor agents; rheumatic arthritis; gastrointestinal disorders; antiinflamamtory agents
03/24/2005US20050065090 Wound healing agents; hydration; wrinkle resistance; aging resistance; radiation resistance; forming collagen, , fibronectin
03/24/2005US20050065071 Cyclic analogs of human parathyroid hormone for the treatment of conditions characterized by hyperproliferative skin cells
03/24/2005US20050064586 Somatic cell derived embryonic stem cells and its differentiated cells
03/24/2005US20050064539 Glycoprotein and process for producing the same
03/24/2005US20050064530 Production of adenine nucleotide translocator (ant), novel ant ligands and screening assays therefor
03/24/2005US20050064491 Transport protein for use as tool in identifying modulator for treatment of sleep, nervous suystem, anixety, eating, cardiovascular and pain disordere
03/24/2005US20050064458 Nucleotide sequences coding membrane protein for use in diagnosis, prevention and treatnment of cell proliferative, nervous system, metabolic and inflammatory disorders
03/24/2005US20050064453 Kit which utilizes interleukin-1-related gene as diagnostic/prognostic tool in detection of urogenital disorders; genomics and bioinformatics
03/24/2005US20050064048 Compositions comprising organic extracts of geum japonicum thunb var. and the use thereof
03/24/2005US20050063971 Monoclonal or humanized antibodies that immunospecifically bind to FGF-CX or any derivative, variant, mutant, polypeptide fragment, polynucleotide or antibody
03/24/2005US20050063964 A natural enzymatic starter and water are added to a rye fine or coarse meal, heated fermentation to form maltose, further addition of meal and fermentation with a lactic acid bacteria, acidification; cosmetics
03/24/2005US20050063931 Via peptide which is a NK1-receptor (neurokinin-1) antagonist
03/24/2005DE102004028302A1 Stimulierung der Synthese und der Aktivität einer Isoform der Lysyloxidase-ähnlichen LOXL zum Stimulieren der Bildung von elastischen Fasern Stimulation of the synthesis and the activity of one isoform of the lysyl oxidase-like LOXL for stimulating the formation of elastic fibers
03/24/2005DE102004028300A1 Stimulierung der Aktivität eines Isoform des Lysyloxidase zum Bekämpfen von einigen Pathologien, die durch eine unvollständige, fehlende oder desorganisierte Elastogenese verursacht sind Stimulation of the activity of an isoform of the lysyl oxidase for controlling some pathologies which are caused by an incomplete, missing or disorganized elastogenesis
03/24/2005CA2538617A1 Skincare compositions comprising salicylic acid
03/24/2005CA2538429A1 Antibacterial drug for propionibacterium acnes
03/23/2005EP1516876A1 Mediators of hedgehog signalling pathways, compositions and uses related thereto
03/23/2005EP1516872A1 Novel azasugar derivative and drug containing the same as the active ingredient
03/23/2005EP1515978A1 Sulfur-containing phospholipid derivatives
03/23/2005EP1515975A1 Benzofused heteroaryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
03/23/2005EP1515966A1 Hydroxy pyranone derivative and preparation method thereof
03/23/2005EP1515959A1 Pharmaceutical salts of reboxetine
03/23/2005EP1515955A2 Chemical process
03/23/2005EP1515753A1 Pharmaceutical use of nitric oxide, heme oxygenase-1 and products of heme degradation
03/23/2005EP1515743A2 Use of osteoprotegerin for the prevention and/or treatment of fibrosis/sclerosis
03/23/2005EP1515742A2 Genes involved in regulating angiogenesis, pharmaceutical preparations containing same and applications thereof
03/23/2005EP1515734A1 Honey-based skin care preparation
03/23/2005EP1515727A2 (halo-benzo carbonyl)heterobicyclic p38 kinase inhibiting agents
03/23/2005EP1515719A2 Enhancing treatment of mdr cancer with adenosine a3 antagonists
03/23/2005EP1515718A2 Modulation of activation of glucocorticoid receptors by breakdown products of glucocorticoids
03/23/2005EP1515716A2 Indole derivatives having anti-angiogenetic activity
03/23/2005EP1515715A2 Hair and nail treatments using alkanolamines
03/23/2005EP1515712A2 Use of taurine for the treatment of alopecia
03/23/2005EP1515710A1 Method of treating rosacea by topical application of a cyclohexane derivative
03/23/2005EP1515680A2 Use of thio-oxindole derivatives in treatment of skin disorders
03/23/2005EP1345618B1 Chlorzoxazone for the treatment of psoriasis
03/23/2005EP1328268B1 Combination of catechin and quercetin for pharmaceutical or dietary use
03/23/2005EP1227764B1 Microdermabrasion device
03/23/2005EP1100516B1 Extracts of feverfew (tanacetum parthenium) against inflammatory disorders
03/23/2005EP1047397B1 Topical compositions for enhancing glutathione production
03/23/2005EP1027064B1 A process for the removal of undersired toxic alkaloids from plants or from vegetable preparations
03/23/2005CN1599748A Novel peptides and medicinal uses thereof
03/23/2005CN1599745A Crystalline form of a ribofuranosyluronamide derivative; a human adenosine a2a receptor agonist
03/23/2005CN1599741A Thioether substituted imidazoquinolines
03/23/2005CN1599740A Amide substituted imidazopyridines
03/23/2005CN1599739A Sulfonamido substituted imidazopyridines
03/23/2005CN1599738A Urea substituted imidazopyridines
03/23/2005CN1599737A Ring fused pyrazole derivatives
03/23/2005CN1599734A 3, 4-di-substituted maleimide compounds as CXC-chemokine receptor antagonists
03/23/2005CN1599726A Pyrimidine compounds
03/23/2005CN1599721A CCR-3 receptor antagonists VII
03/23/2005CN1599620A Process of preparation of formulations of the peptide angiotensin-(1-7) and its analogues, agonistic and antagonists using cyclodextrins, lipossomes and biodegradable polymers and/or mixtures and prod
03/23/2005CN1599619A Methods and compositions for treating dermal lesions
03/23/2005CN1599618A Stabilization of hypoxia inducible factor (HIF) alpha
03/23/2005CN1599616A Storage-stable human fibrinogen solutions
03/23/2005CN1599613A Combinations for the treatment of immunoinflammatory disorders
03/23/2005CN1599607A Carbinols for the treatment of neuropathic dysfunction
03/23/2005CN1597695A Active GSLL-39 fragment of gene recombination human antibacterial peptide mh CAP-18 and its preparation method and use
03/23/2005CN1597667A Quinazoline derivatives as angiogenesis inhibitors
03/23/2005CN1597662A A kind of aromatic acid amide compound its preparation method and use
03/23/2005CN1597008A Local preparation containing poloxamer and other microbe killing agent and applicator
03/23/2005CN1596983A Composition of nanometer SOD and ginseng or its extract and its preparation method
03/23/2005CN1596981A Composition of nanometer SOD and pueraria root or its extract and its preparation method
03/23/2005CN1596979A Method for the treatment of fibrosis using an antagonist of the integrin alpha-4 subunit
03/23/2005CN1596976A Polypeptide vaccine capable of effectively preventing pointed condyloma
03/23/2005CN1596969A Psoriasis treatment liquid
03/23/2005CN1596959A Burn dispersion powder
03/23/2005CN1596953A Medicine for treating anaphylactic dermatosis
03/23/2005CN1596951A Phellodendron bark disperse tablet and its preparation method
03/23/2005CN1596950A Mixture for treating acute condyloma
03/23/2005CN1596946A Skin and mueosa tissue disinfectant and its processing method
03/23/2005CN1596932A Ointment for treating flat wart and its formula
03/23/2005CN1596912A Multifunctional compound medicine for treating burn, chemical substance ambustion and its skin disease
03/23/2005CN1596908A Sterilization bacteria inhibition compound iodophor medicine and its preparation and preparation technology
03/23/2005CN1596897A Itraconazole injection and its preparation method
03/23/2005CN1193788C Beta 2-adrenergic receptor agonist
03/23/2005CN1193786C Preparation of Chinese herbal medicine for treating cold injury, various indurations and swelling, pain as well as its preparing method
03/23/2005CN1193780C Excernally applied plaster using paper as paper as carrier for treating beriberi
03/23/2005CN1193778C Medicine liquid for treating burns and scalds
03/23/2005CN1193760C Licorzinc solution composition, preparation process tereof and licorxinc preparation
03/23/2005CN1193746C Substituted nitrobenzene derimative for medicine and other use
03/23/2005CN1193738C Herbal skin care paste
03/22/2005US6869973 Nitrosated and nitrosylated taxanes, compositions and methods of use
03/22/2005US6869962 Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
03/22/2005US6869952 Such as 4-(4-fluoro-2-methyl-1H-indol-5-yloxy)-5-methyl-pyrrolo(2,1-f)(1,2,4)triazin-6-ol; for treament of cancer
03/22/2005US6869945 Antihistamines; respiratory system disorders; antiinflammatory agents
03/22/2005US6869941 Combination of drospirenone and an estrogen sulphamate for HRT
03/22/2005US6869789 Heparinase III and uses thereof
03/22/2005CA2125189C Pyropheophorbides and their use in photodynamic therapy
03/17/2005WO2005024009A1 Modulation of hair growth via sgk3
03/17/2005WO2005023771A1 Chemokine receptor antagonist and medical use thereof